UK markets open in 4 hours 24 minutes

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
434.92+13.42 (+3.18%)
At close: 3:57PM EDT
Sign in to post a message.
  • M
    Manos
    Why is it falling right now though? I can't see any bad press or anything (will be buying the dip ofc)
  • H
    Herman
    We will see 100 this year!
    Takeover rumours are increased
  • L
    Leon
    Down 4% extended hours, please keep staying low so I can buy more
  • P
    PAUL
    Anyone know why the recent increase sp?
  • S
    Stocks Technical
    Hoping for this GMAB bounce intraday. Nice mention alongside a few cancer stocks today so I'm happy so far https://valuemarket.exchange/45r6sh
  • B
    Bunny
    My target price is 57 to 65 dollars in the short term. In the long term, the growth could be exponential.
  • K
    Kroptie
    Even Pipeline expanding. genmab is like a mutual find of biotech with over 20 candidates over 33 different indications
  • J
    James
    It look be just a matter of time until someone takes this company out. Great pipeline/no debt and plenty of cash on hand. Just hold and wait.
  • J
    James
    Looks like things are starting are starting to heat up. Horizon report on may 5th be interesting and seeing how the Tepezza sales are going. I have a feeling in 2 years this stock price will double as there is a lot coming down the pipeline just my gut from what I have been reading
  • D
    Div
    Great pipeline and Darzalex Fast Pro off to a good start even during Covid. Can’t get a better pipeline and already in the black for a young US company- IPO wasn’t that long ago! Long and strong/ forget that sell side today!! Want to get the shares cheaper as the analysts wake up to a great company!!
  • B
    Bunny
    Free Cash Flow increasing from 1.2 billions to over 6 billions DKK. That is almost 600% jump with further growth and recurring revenue ! This is a super growth stock. Stock price will jump.
  • K
    Kroptie
    When JNJ took out Actelion for $30 billion it had no earnings and paid $280 a share. Genmab has $250 million USD net income already and is valued at only 6 billion.Putting same price on Genmab would be $500
  • I
    Imme
    What is this ...GMAB gets FDA approval on an MS drug and no market reaction??? I just bought some... hoping for markets react positively....
  • M
    ML
    Copenhagen, Denmark; January 15, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (U.S. FDA) has approved the use of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide, and dexamethasone (VCd) for the treatment of adult patients with newly diagnosed light-chain (AL) amyloidosis.
  • K
    Kroptie
    I listened to conference. Newest Darzulex indication just approved by FDA yesterday could double royalty income from JNJ in coming year
  • W
    William
    dont know why this didnt move on the abbvie news.
  • K
    Kroptie
    Split shares because management feels undervalued
  • P
    Peter K.
    The Hubrecht Institute and Genmab have developed a new robot, the STRIP-1 – test robot (Systematic Testing with Robotics & Innovation in Pandemic), capable of processing around 20,000 samples per 24 hours for SARS-CoV-2 testing, which means faster processing in a short duration of time. https://youtu.be/fE-4Krgjl54
  • W
    William
    Just sit tight. One approval after another this stock will be great! I admit I just rang the tegister for 100 shares but I'm holding the rest
  • K
    Kroptie
    The Alcyone study was very positive reducing mortality by 50%. these are huge numbers and the Chairman speaks very well of JNJ . JNJ took out Action for a big number. This is perennial rumored takeout by JNJ which partners with Genmab.Based on Action numbers Genmab is worth $500 or ADR of $250.